Paraophthalmic Aneurysm: Symptoms, Diagnosis, & Treatment

Paraophthalmic aneurysms are bulges in the wall of the internal carotid artery near where the ophthalmic artery branches off, sitting in close quarters with the optic nerve and other critical structures at the base of the skull. They account for roughly 5 to 10 percent of intradural brain aneurysms and often go unnoticed until they grow large enough to press on surrounding nerves or, less commonly, rupture and bleed.¹ Because of where they sit, their symptoms, the way doctors find them, and the available treatments all carry unique considerations that differ from aneurysms elsewhere in the brain.

Where Exactly These Aneurysms Sit

The paraophthalmic segment of the internal carotid artery starts at the upper edge of the cavernous sinus, the bony channel the artery passes through beneath the brain, and ends where the posterior communicating artery branches off.¹ This short stretch of artery is packed with anatomical landmarks. The optic nerve crosses just above it, the ophthalmic artery branches from it to supply the eye, and a tough ring of tissue called the distal dural ring marks the point where the artery enters the space inside the skull lining. Aneurysms can sprout from different points along this segment and project in different directions, which matters because the direction of the bulge determines which nearby nerves it threatens and how accessible it is for treatment.

Terms like “paraclinoid aneurysm,” “carotid-ophthalmic aneurysm,” and “superior hypophyseal aneurysm” all overlap with paraophthalmic aneurysm and are sometimes used interchangeably in clinical practice. The naming confusion stems from different classification systems focusing on different landmarks, such as the anterior clinoid process (a small bony projection), the ophthalmic artery origin, or the superior hypophyseal artery. For the person living with one, the practical takeaway is the same: this is an aneurysm sitting in a tight, surgically demanding neighborhood near the optic nerve.

How They Form

Paraophthalmic aneurysms develop where blood flow hammers the arterial wall with unusual force. The internal carotid artery makes several sharp bends as it climbs from the neck into the skull, and at each bend the flowing blood strikes the outer wall head-on. Research using computational models has shown that tighter bends create stronger hemodynamic stresses, and aneurysms tend to sprout near the point of maximum flow impact.² Flow force alone, however, is usually not enough. Experimental work in animal models has demonstrated that aneurysms are most likely to appear when hemodynamic stress acts on a wall that is already weakened, with disrupted elastic fibers, thinned muscle layers, and increased activity of enzymes that break down the structural framework of the vessel.³

The same risk factors that promote aneurysms elsewhere in the brain apply here: smoking, high blood pressure, family history, and connective tissue disorders. Women are diagnosed more often than men, a pattern especially pronounced for aneurysms in this particular segment. This sex difference is thought to relate in part to hormonal influences on arterial wall integrity, though the exact mechanism remains debated.

Symptoms and Warning Signs

Many paraophthalmic aneurysms produce no symptoms at all and are discovered incidentally on brain imaging done for unrelated reasons, such as a headache workup or a head injury scan. When symptoms do appear, visual problems dominate the picture because of the optic nerve running so close by.

As a paraophthalmic aneurysm grows, it can push against the optic nerve and behave like a slowly expanding mass inside the skull.⁴ The visual changes this causes tend to creep in gradually. You might notice a blind spot or a narrowing of your visual field in one eye, or a slow decline in how sharply you can see. Because the loss is often painless and can initially affect peripheral vision, it is easy to dismiss or attribute to aging or an eye problem. In one documented case, a patient with bilateral paraophthalmic aneurysms presented with complete visual field loss in one eye and an early arcuate scotoma, a distinctive arc-shaped blind spot, in the other, while standard retinal imaging appeared normal.⁵ That pattern, progressive field loss with a normal-looking retina, should prompt imaging of the arteries near the optic nerve.

Less commonly, a paraophthalmic aneurysm announces itself catastrophically when it ruptures, causing subarachnoid hemorrhage. The hallmark is a sudden, explosive headache, often described as the worst of a person’s life, sometimes accompanied by nausea, a stiff neck, loss of consciousness, or neurological deficits. Rupture from this location is a neurosurgical emergency with all the attendant risks of brain hemorrhage, including vasospasm, where blood vessels go into prolonged contraction in the days following the bleed.

How Paraophthalmic Aneurysms Are Diagnosed

Three-dimensional digital subtraction angiography, or 3D-DSA, remains the reference standard for evaluating brain aneurysms. It involves threading a catheter into the artery and injecting contrast dye while a rotating X-ray camera captures images, producing a detailed three-dimensional map of the aneurysm, its neck, and its relationship to the parent artery and nearby branches.⁶ This level of detail is especially valuable for paraophthalmic aneurysms because the bony skull base can obscure small aneurysms on less invasive scans, and 3D-DSA can reveal them even when they are hidden beneath major arteries or close to bone.⁷

Because 3D-DSA is an invasive procedure with its own small risks, most people are first screened with CT angiography or MR angiography. A meta-analysis comparing the two noninvasive techniques found that both perform similarly for detecting intracranial aneurysms overall, with sensitivities around 80 to 84 percent.⁸ However, accuracy for both methods drops when the aneurysm sits along the internal carotid artery compared with other locations.⁹ This is partly because the dense bone of the skull base and the cavernous sinus create imaging artifacts that can mimic or mask an aneurysm. Conventional angiography also remains better at distinguishing normal anatomical variants, like infundibular widenings, from true aneurysms and at visualizing blood flow direction and collateral circulation.⁷

For patients whose initial symptom is visual loss, the diagnostic path often starts in an eye doctor’s office. Standard ophthalmic tests like visual field perimetry can reveal patterns of field loss that point toward compression of the optic nerve or chiasm rather than a disease of the eye itself. When that pattern emerges, neuroimaging follows to look for a compressive cause, including an aneurysm.

Treatment by Endovascular Methods

Endovascular treatment, which means working from inside the blood vessel using catheters threaded up from the groin or wrist, has become the dominant approach for paraophthalmic aneurysms. Several techniques exist, and the choice depends on the aneurysm’s size, shape, neck width, and whether it has ruptured.

Coil embolization involves packing the aneurysm sac with tiny platinum coils through a microcatheter, encouraging the blood inside to clot and sealing off the bulge from the circulation. For ruptured paraophthalmic aneurysms, coiling is generally considered the first-line endovascular option because it does not require the long-term blood-thinning medication that other devices demand, an important advantage in the acute setting of a brain bleed.¹ A drawback of simple coiling is recurrence: the aneurysm can reopen over time as coils compact. In one single-center comparison, aneurysms treated with coils alone recurred at a rate of about 21 percent, while those treated with a stent placed across the aneurysm neck to hold the coils in place recurred at only about 3 percent. The stent-assisted group also showed a higher rate of progressive occlusion during follow-up.¹⁰

Flow diverters are a newer category of device: fine-mesh stents placed across the aneurysm neck inside the parent artery. Rather than filling the sac, they redirect blood flow away from the aneurysm, causing it to gradually clot and shrink. For ophthalmic-segment aneurysms, flow diversion has shown strong long-term results, with complete occlusion reported in roughly 65 percent of patients at six months and 96 percent at three years in one series.¹¹ The trade-off is that flow diverters require dual antiplatelet therapy, typically aspirin plus a second agent, for months after placement to prevent clots from forming on the device. That requirement makes flow diverters less suitable for ruptured aneurysms, where antiplatelet drugs could worsen bleeding.

Surgical Clipping and Bypass Procedures

Open microsurgical clipping, where a small metal clip is placed across the aneurysm’s neck through a craniotomy, was the standard treatment before endovascular methods matured. For paraophthalmic aneurysms specifically, clipping is technically demanding because the surgeon must work around the optic nerve, remove part of the anterior clinoid bone to expose the artery, and open the dural ring, all in a deep, narrow corridor. A mini-pterional craniotomy with a trans-sylvian approach and, when needed, intradural anterior clinoidectomy using a diamond drill under constant irrigation is a typical technique.¹² Precise dissection around the aneurysm and careful clip application are critical to preserving vision, and aggressive postoperative medical management may help reduce delayed visual complications.¹³

For giant or complex aneurysms that cannot be safely clipped or coiled, an alternative strategy involves sacrificing the parent artery after first creating a detour for blood flow. In this approach, an extracranial-to-intracranial bypass graft is constructed, typically connecting a scalp artery to a brain artery, before the diseased segment of the internal carotid is deliberately occluded. This shuts off blood flow to the aneurysm while the bypass keeps the brain supplied. Early experience with this technique showed it could reduce the risk of stroke that would otherwise follow parent vessel occlusion.¹⁴ A more recent series explored staging the bypass and the occlusion as separate procedures rather than doing both at once, allowing the bypass graft time to mature before the artery is blocked. In that series, aneurysms disappeared in over 90 percent of patients and about 92 percent showed resolution at last follow-up, with a low rate of ischemic complications.¹⁵

Visual Outcomes Across Treatment Types

Vision is the outcome that patients with paraophthalmic aneurysms worry about most, and the data here are worth a close look. A systematic review and meta-analysis pooling over 2,400 patients with paraclinoid aneurysms found that about 38 percent presented with visual symptoms before treatment. Among those patients, vision improved after treatment in roughly 58 percent of clipping cases, 49 percent of coiling cases, and 71 percent of flow-diversion cases. Vision worsened in about 11 percent after clipping, 9 percent after coiling, and 5 percent after flow diversion.¹⁶ Among patients who had normal vision before treatment, the rate of developing a new visual deficit was low across all three methods, around 1 percent or less.¹⁶

A separate comparative study found a more pronounced gap: post-treatment visual deficits occurred in about 16 percent of patients who underwent clipping versus roughly 2 percent of those who underwent coiling, a statistically significant difference.¹⁷ This is consistent with the physical reality of open surgery near the optic nerve: dissecting tissue away from the nerve, removing bone, and applying a clip all carry some risk of mechanical or thermal injury to the nerve even in skilled hands.

These numbers do not mean endovascular treatment is always the better choice. Some aneurysm shapes are poorly suited to coiling or flow diversion. Very broad-necked aneurysms, those incorporating the origin of the ophthalmic artery, or those that have already bled and require immediate treatment without antiplatelet therapy may be better served by surgery. The decision is individualized and depends on a conversation between the patient, a cerebrovascular neurosurgeon, and a neurointerventionalist.

The Flow Diverter and the Ophthalmic Artery

One concern specific to treating paraophthalmic aneurysms with flow diverters is the fate of the ophthalmic artery itself. Because the ophthalmic artery originates right at the site where the flow diverter sits, the device’s mesh inevitably covers the artery’s opening. In theory, this could starve the eye of blood. In practice, most patients tolerate it because the ophthalmic artery has collateral supply from branches of the external carotid artery that can compensate. But not everyone has robust collaterals, and the risk is not zero.

Computational modeling has shown that the degree of flow reduction in the ophthalmic artery depends heavily on which flow diverter is used. Different devices have different mesh densities, and the effective coverage at the ophthalmic artery opening can differ substantially from the coverage listed on the product label because the artery’s curved geometry stretches the mesh unevenly. In one simulation, two flow diverters from the same product family reduced blood flow to the ophthalmic artery by about 19 and 27 percent respectively, and the denser device caused notably more occlusion of ophthalmic artery branches, raising a higher estimated risk of ocular ischemia.¹⁸ For clinicians, this underscores that device selection is not one-size-fits-all: the patient’s specific anatomy and collateral supply should inform which flow diverter, if any, is the right choice.

Incidental Discovery and the Watch-and-Wait Question

A growing number of paraophthalmic aneurysms are found by accident on MRI or CT scans done for headaches, dizziness, or other complaints. When an aneurysm is small, unruptured, and causing no symptoms, treatment is not always the obvious move. Every intervention, whether endovascular or surgical, carries its own risks: stroke, bleeding, vision loss, or complications from anesthesia and antiplatelet drugs. For a tiny, stable aneurysm in a patient with no symptoms, those procedural risks can exceed the natural risk of the aneurysm itself over a given time frame.

Factors that push toward treatment include larger size, irregular shape, a history of growth on serial imaging, a family history of aneurysm rupture, younger age (because a longer remaining life span means more cumulative exposure to rupture risk), and smoking. Factors that favor observation include small size, stable appearance over time, older age, and significant medical comorbidities that raise procedural risk. There is no universal size cutoff that dictates treatment, though aneurysms larger than about 7 millimeters generally receive more serious consideration for intervention. Patients managed conservatively are followed with periodic imaging, typically MR angiography, to watch for growth.

Antiplatelet Management Challenges

Antiplatelet therapy after flow-diverter placement or stent-assisted coiling is a balancing act that deserves attention because it directly affects the patient’s daily life and safety. Most protocols call for dual antiplatelet therapy, aspirin plus a second agent like clopidogrel, starting before the procedure and continuing for months afterward. The concern is twofold: too little antiplatelet effect risks clot formation on the device, which can block the artery and cause a stroke, while too much raises the risk of bleeding, including brain hemorrhage.

People respond to these drugs differently. Genetic variations in drug metabolism can make someone a poor responder to clopidogrel, leaving the device inadequately protected, or a hyperresponder, increasing the bleeding risk. Some centers now use platelet function testing before and after the procedure to adjust drug dosages. This is one of the reasons that for ruptured paraophthalmic aneurysms, coil embolization without a stent is often preferred when technically feasible: it avoids the antiplatelet dilemma entirely at a moment when the brain is already dealing with a hemorrhage.¹ For unruptured aneurysms that are straightforward to coil, some authors have argued that the simplicity of coiling should be weighed against the long-term durability advantages of flow diversion, particularly in younger patients who would otherwise face decades of follow-up imaging and possible retreatment.

When an Eye Doctor Is the First to Suspect an Aneurysm

Because visual symptoms are often the earliest sign of a paraophthalmic aneurysm, optometrists and ophthalmologists sometimes detect these lesions before any neurologist or neurosurgeon is involved. A pattern of progressive visual field loss in one eye, especially when the retina and optic disc appear normal on routine examination, should trigger suspicion of a compressive lesion behind the eye.⁴ Optic nerve head swelling, if present, can suggest elevated pressure from a nearby mass, but its absence does not rule out an aneurysm.

The message for patients is that unexplained, painless, progressive vision loss in one eye warrants imaging of the blood vessels around the optic nerve, not just a stronger glasses prescription. Larger aneurysms pressing on the optic nerve can compress it severely enough to cause irreversible damage if left untreated, so prompt referral for neurovascular imaging matters. The visual loss that comes from nerve compression by an aneurysm can sometimes be partially reversed with treatment, as the meta-analysis data on post-treatment visual improvement show, but the degree of recovery depends in part on how long the nerve has been compressed and how much damage has accumulated before the pressure is relieved.

1
PubMed Central. Endovascular treatment of aneurysms of the paraophthalmic segment of the internal carotid artery: Current status
2
PubMed Central. High hemodynamic stresses induce aneurysms at internal carotid artery bends
3
PubMed. Arterial wall degeneration plus hemodynamic insult cause arterial wall remodeling and nascent aneurysm formation at specific sites in dogs
4
Optometry – Journal of the American Optometric Association. Enlargement of internal carotid artery aneurysm presenting with severe visual sequela: A case report and anatomy review
5
Archivos de la Sociedad Española de Oftalmología (English Edition). Bilateral paraophthalmic carotid artery aneurysm presenting with visual loss
6
PubMed Central. Diagnostic Value of Low-Dose 256-Slice Spiral CT Angiography, MR Angiography, and 3D-DSA in Cerebral Aneurysms
7
Neurosurgery. Comparison Between CTA and Digital Subtraction Angiography in the Diagnosis of Ruptured Aneurysms
8
PubMed Central. Meta-analysis of computed tomography angiography versus magnetic resonance angiography for intracranial aneurysm
9
PubMed. Intracranial aneurysms: CT angiography and MR angiography for detection prospective blinded comparison in a large patient cohort
10
PubMed Central. Simple Coiling versus Stent-Assisted Coiling of Paraclinoid Aneurysms: Radiological Outcome in a Single Center Study
11
PubMed Central. Flow Diversion for Ophthalmic Artery Aneurysms
12
PubMed Central. Endovascular-assisted microsurgical clipping of ophthalmic segment aneurysms
13
PubMed. Microsurgical clipping of ophthalmic artery aneurysms: surgical results and visual outcomes with 208 aneurysms
14
PubMed Central. EC-IC bypass for cavernous carotid aneurysms: An initial experience with twelve patients
15
PubMed. A novel staged parent artery occlusion following extracranial-intracranial bypass for giant intracranial aneurysms: case series and hemodynamic insights via 4D flow MRI
16
Journal of Neurosurgery. Vision outcomes in patients with paraclinoid aneurysms treated with clipping, coiling, or flow diversion: a systematic review and meta-analysis
17
Neurointervention. Comparison of Visual Outcomes of Ophthalmic Artery Aneurysms Treated with Microsurgical Clipping and Endovascular Coiling
18
PubMed Central. How Flow Diverter Selection Can Affect the Flow Changes within a Jailed Ophthalmic Artery: A Computational Fluid Dynamics Study